Beede S D, Ballard D J, James E M, Ilstrup D M, Hallet J W
Mayo Medical School, Rochester, MN.
Arch Intern Med. 1990 Mar;150(3):549-51.
Although selective screening for an abdominal aortic aneurysm (AAA) by abdominal palpation aimed at detecting AAAs has engendered considerable support, no population-based data pertaining to the positive predictive value (PPV) of the clinical assessment of AAAs in routine clinical practice are available. Therefore, we used the unique resources of the Rochester (Minn) Epidemiology Project and the Mayo Clinic computerized abdominal ultrasonography database to identify all residents of Olmsted County, Minnesota,who underwent ultrasound examination for a clinically suspected AAA between November 1, 1985, and October 31, 1987. Of 116 residents who were suspected of having an AAA on abdominal palpation and were referred for an ultrasound examination for confirmation, 17 patients had a 3.5-cm or greater AAA by ultrasound examination (PPV = 14.7%). The probability of AAA by ultrasound examination (PPV = 14.7%). The probability of AAA documentation by ultrasound examination given clinical suspicion of an AAA was associated with higher body mass index, older age,and presence of other macrovascular disease. In 17 patients aged 70 years or younger, without other macrovascular disease and with body mass index of 24 or less, only 1 had an AAA of 3.5 cm or greater (PPV = 6%), while 10 of 20 patients aged 70 years or older, with macrovascular disease,and with body mass index greater than 24 had an AAA of 3.5 cm or greater (PPV = 50%). These population-based data that highlight the poor PPV of the clinical assessment for AAAs indicate that abdominal palpation aimed at detecting AAAs as part of a periodic health examination may lead to a much higher rate of false-positive results than indicated by previous referral-based data. Further research is needed to identify patient subgroups in whom abdominal palpation for detection of AAAs will be cost-effective with respect to reduction in AAA mortality.
尽管通过腹部触诊对腹主动脉瘤(AAA)进行选择性筛查以检测AAA已获得相当多的支持,但尚无关于常规临床实践中AAA临床评估的阳性预测值(PPV)的基于人群的数据。因此,我们利用罗切斯特(明尼苏达州)流行病学项目和梅奥诊所计算机化腹部超声数据库的独特资源,确定了明尼苏达州奥尔姆斯特德县所有在1985年11月1日至1987年10月31日期间因临床怀疑患有AAA而接受超声检查的居民。在116名因腹部触诊怀疑患有AAA并被转诊进行超声检查以确诊的居民中,17名患者经超声检查发现AAA直径达3.5厘米或更大(PPV = 14.7%)。经超声检查发现AAA的概率(PPV = 14.7%)。临床怀疑患有AAA时经超声检查记录到AAA的概率与较高的体重指数、老年以及其他大血管疾病的存在有关。在17名70岁及以下、无其他大血管疾病且体重指数为24或更低的患者中,只有1名患者的AAA直径达3.5厘米或更大(PPV = 6%),而在20名70岁及以上、患有大血管疾病且体重指数大于24的患者中,有10名患者的AAA直径达3.5厘米或更大(PPV = 50%)。这些基于人群的数据突出了AAA临床评估的PPV较差,表明作为定期健康检查一部分旨在检测AAA的腹部触诊可能导致比以前基于转诊的数据所显示的更高的假阳性结果率。需要进一步研究以确定在哪些患者亚组中,通过腹部触诊检测AAA在降低AAA死亡率方面具有成本效益。